Abstract:Cortactin, a cytoskeletal protein and substrate of src kinase, is implicated in tumor aggressiveness. However, its role in bone cell differentiation remains unknown. The current study revealed that cortactin was upregulated during osteoblast and adipocyte differentiation. Functional experiments demonstrated that cortactin promoted the differentiation of mesenchymal stem/progenitor cells into osteogenic and adipogenic lineages. Mechanistically, cortactin was able to stabilize the protein level of mechanistic target of rapamycin kinase (mTOR), leading to the activation of mTOR signaling. In-depth investigation revealed that cortactin could bind with casitas B lineage lymphoma-c (c-CBL) and counteract the function of c-CBL, a known E3 ubiquitin ligase responsible for the proteasomal degradation of mTOR. Silencing c-Cbl alleviated the impaired differentiation of osteoblasts and adipocytes caused by cortactin siRNA, while silencing mTOR mitigated the stimulation of osteoblast and adipocyte differentiation induced by cortactin overexpression. Notably, transplantation of cortactin-silenced bone marrow stromal cells (BMSCs) into the marrow of mice led to a reduction in trabecular bone mass, accompanied by a decrease in osteoblasts and an increase in osteoclasts. Furthermore, cortactin-silenced BMSCs expressed higher levels of RANKL than control BMSCs did, and promoted osteoclast differentiation when cocultured with bone marrow-derived osteoclast precursor cells. This study provides evidence that cortactin favors osteoblast differentiation by counteracting the c-CBL-induced degradation of mTOR and inhibits osteoclast differentiation by downregulating the expression of RANKL. It also suggests that maintaining an appropriate level of cortactin expression may be advantageous for maintaining bone homeostasis.

mTORC1 Prevents Preosteoblast Differentiation through the Notch Signaling Pathway

mTORC1 Activation in Osteoclasts Prevents Bone Loss in a Mouse Model of Osteoporosis

Inactivation of Regulatory-associated Protein of Mtor (raptor)/mammalian Target of Rapamycin Complex 1 (mtorc1) Signaling in Osteoclasts Increases Bone Mass by Inhibiting Osteoclast Differentiation in Mice.

RhoA Promotes Osteoclastogenesis and Regulates Bone Remodeling Through Mtor-Nfatc1 Signaling.

Notch Signaling Maintains Bone Marrow Mesenchymal Progenitors by Suppressing Osteoblast Differentiation

Bone Size and Quality Regulation: Concerted Actions of mTOR in Mesenchymal Stromal Cells and Osteoclasts

The mTORC2 Component Rictor Is Required for Load-Induced Bone Formation in Late-Stage Skeletal Cells

Pharmacological Inhibition of S6K1 Impairs Self‐renewal and Osteogenic Differentiation of Bone Marrow Stromal Cells

mTOR/Raptor signaling is critical for skeletogenesis in mice through the regulation of Runx2 expression

Dynamic control of mTORC1 facilitates bone healing in mice

Rictor/mTORC2 Loss in Osteoblasts Impairs Bone Mass and Strength.

mTOR signaling contributes to chondrocyte differentiation.

Mtorc1 Maintains the Tumorigenicity of SSEA-4+ High-Grade Osteosarcoma

mTORC2-mediated cell-cell interaction promote BMP4-induced WNT activation and mesoderm differentiation

Mtor and the Differentiation of Mesenchymal Stem Cells.

mTORC1 Activation Promotes Spermatogonial Differentiation and Causes Subfertility in Mice

Phosphoproteome Profiling Revealed The Importance Of Mtor Inhibition On Cdk1 Activation To Further Regulate Cell Cycle Progression

Mtorc1 and Mtorc2 Play Different Roles in Regulating Cardiomyocyte Differentiation from Embryonic Stem Cells.

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of Mtorc1 in Osteoclast Formation.

Cortactin controls bone homeostasis through regulating the differentiation of osteoblasts and osteoclasts

mTORC1 and STAT3 signalings are indispensable for in vitro TGFβ1-dependent Three-Dimensional (3D) tendon construct.